T-cell-based immunotherapies hold promise for the treatment of many types of cancer, with
three approved products for B-cell malignancies and a large pipeline of treatments in clinical …

Cancer immunotherapy is revolutionizing oncology. However, dose-limiting toxicities and
low patient response rates remain major challenges in the clinic. Cancer nanomedicine in …

More than 60 years ago, the effect whereby radiotherapy at one site may lead to regression
of metastatic cancer at distant sites that are not irradiated was described and called the …

Terahertz (THz) radiation has attracted considerable attention in medical imaging owing to
its nonionizing and spectral fingerprinting characteristics. To date, most studies have …

Nanomedicine has emerged as a promising mean to improve theranostic efficacy and
reduce side effects. Currently, only very small percentage of injected dose reaches the solid …

Nanoparticles are defined as solid colloidal particles ranging in size from 10 to 1000 nm.
Nanoparticles offer many benefits to larger particles such as increased surface-to-volume …

The arrival of cell-based therapies is a revolution in medicine. However, its safe clinical
application in a rational manner depends on reliable, clinically applicable methods for …

The unique properties of gold nanoparticles, their rich surface chemistry, and low toxicity as
well as easy methods of synthesis have promoted conjugation of the particles with …

Recently, diverse functional materials that take subcellular structures as therapeutic targets
are playing increasingly important roles in cancer therapy. Here, particular emphasis is …

Exosomes are emerging as effective therapeutic tools for various pathologies. These
extracellular vesicles can bypass biological barriers, including the blood-brain barrier, and …